BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development BioMed X Institute Jun 29, 2023 17:00 HKT/SGT Read More
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development BioMed X Institute Jun 29, 2023 17:00 HKT/SGT Read More
エーザイ、Gates Ventures、Health Data Research UK、LifeArc、およびエジンバラ大学は認知症の課題解決に寄与するデジタル・ソリューション開発をめざす共同研究「NEURii」を開始 Eisai Jun 29, 2023 12:00 JST Read More
四环医药:旗下轩竹生物创新药品安奈拉唑钠肠溶片获国家药监局批准上市 Sihuan Pharmaceutical Holdings Group Ltd. Jun 27, 2023 13:02 HKT/SGT Read More
四環醫藥:旗下軒竹生物創新藥品安奈拉唑鈉腸溶片獲國家藥監局批准上市 Sihuan Pharmaceutical Holdings Group Ltd. Jun 27, 2023 13:01 HKT/SGT Read More
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA Sihuan Pharmaceutical Holdings Group Ltd. Jun 27, 2023 13:00 HKT/SGT Read More
Eisai's "Nouknow" Will Continue to be Utilized for Brain Health Assessment as Part of The FY2023 Dementia Examination Project by Tokyo Bunkyo City Eisai Jun 22, 2023 16:08 HKT/SGT Read More
OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position Envision Pharma Group Jun 15, 2023 19:00 HKT/SGT Read More
Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant Proventus Bioscience Jun 13, 2023 22:00 HKT/SGT Read More
Lipella Pharmaceuticals: Addressing Significant Unmet Need for Cancer Survivors, Delivering Long Term Value for Shareholders PCG Digital Jun 13, 2023 21:00 HKT/SGT Read More
中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎(AD)的新药研究申请获国家药监局药品审评中心受理 SinoMab BioScience Limited Jun 12, 2023 20:45 HKT/SGT Read More
中國抗體SM17再增一項適應症研究申請 針對治療特應性皮炎(AD)的新藥研究申請獲國家藥監局藥品審評中心受理 SinoMab BioScience Limited Jun 12, 2023 20:44 HKT/SGT Read More
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE SinoMab BioScience Limited Jun 12, 2023 20:43 HKT/SGT Read More
FDA Advisory Committee Votes Unanimously to Confirm the Clinical Benefit of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer's Disease Eisai Jun 12, 2023 09:13 HKT/SGT Read More
エーザイ、米国FDA諮問委員会は全会一致でアルツハイマー病治療薬「LEQEMBI(R)」(レカネマブ)の臨床上のベネフィットを支持 Eisai Jun 12, 2023 09:00 JST Read More
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, progresses at full speed in innovative research and development, Presents major research results of birociclib, the start product, at the international stage in ASCO Sihuan Pharmaceutical Holdings Group Ltd. Jun 08, 2023 21:18 HKT/SGT Read More
四环医药旗下轩竹生物创新研发全速前进 携明星产品吡罗西尼重磅研究成果登国际舞台于ASCO亮相 Sihuan Pharmaceutical Holdings Group Ltd. Jun 08, 2023 21:16 HKT/SGT Read More
四環醫藥旗下軒竹生物創新研發全速前進 攜明星產品吡羅西尼重磅研究成果登國際舞台於ASCO亮相 Sihuan Pharmaceutical Holdings Group Ltd. Jun 08, 2023 21:15 HKT/SGT Read More